tryptoquivaline has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brabant, G; Cui, D; Derwahl, M; Xu, S; Zheng, X | 1 |
| Annable, T; Brown, E; Collins, KI; Greenberger, LM; He, H; Rabindran, SK; Singh, M | 1 |
2 other study(ies) available for tryptoquivaline and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells.
Topics: Antibiotics, Antineoplastic; ATP-Binding Cassette Transporters; Biomarkers, Tumor; Carcinoma; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Indoles; Neoplastic Stem Cells; Octamer Transcription Factor-3; Spheroids, Cellular; Thyroid Neoplasms; Verapamil | 2010 |
Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Carcinoma; Colonic Neoplasms; DNA Topoisomerases, Type II; Drug Resistance, Multiple; Humans; Indoles; Mitoxantrone; Multidrug Resistance-Associated Proteins; Tumor Cells, Cultured | 1998 |